Cargando…

Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics

BACKGROUND: Pim-1 is overexpressed in cancer tissues and plays a vital role in carcinogenesis. However, its clinical significance in cancers is not fully verified by meta-analysis, especially in relation to prognosis and clinicopathological features. METHODS: Four databases, PubMed, Embase, Cochrane...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Lin, Chen, Xinyu, Tian, Ge, Liang, Renba, Chen, Xishan, Qin, Yuelan, Chen, Kaihua, Zhu, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290152/
https://www.ncbi.nlm.nih.gov/pubmed/35844176
http://dx.doi.org/10.1177/10732748221106268
_version_ 1784748824623841280
author Lai, Lin
Chen, Xinyu
Tian, Ge
Liang, Renba
Chen, Xishan
Qin, Yuelan
Chen, Kaihua
Zhu, Xiaodong
author_facet Lai, Lin
Chen, Xinyu
Tian, Ge
Liang, Renba
Chen, Xishan
Qin, Yuelan
Chen, Kaihua
Zhu, Xiaodong
author_sort Lai, Lin
collection PubMed
description BACKGROUND: Pim-1 is overexpressed in cancer tissues and plays a vital role in carcinogenesis. However, its clinical significance in cancers is not fully verified by meta-analysis, especially in relation to prognosis and clinicopathological features. METHODS: Four databases, PubMed, Embase, Cochrane Library, and Web of Science, were searched. Literature screening and data extraction according to the inclusion and exclusion criteria. The quality of the included literatures was evaluated using the Newcastle-Ottawa scale and the data analysis was performed using STATA and Review Manager software. RESULTS: 15 articles were finally included for meta-analysis, involving 1651 patients. Effect-size pooling analysis showed that high Pim-1 was related to poor overall survival (OS) (HR 1.68 [95% CI 1.17-2.40], P = .004) and disease-free survival (DFS) (HR 2.15 [95 %CI 1.15-4.01], P = .000). Subgroup analysis indicated that the detection techniques of Pim-1 were the main sources of heterogeneity, and 2 literatures using quantitative polymerase chain reaction (qPCR) for Pim-1mRNA had high homogeneity (I(2) = .0%, P = .321) in OS. Another 13 studies that applied immunohistochemistry (IHC) for Pim-1 protein had significant heterogeneity (I(2)=82.2%, P = .000; I(2)=92%, P = .000) in OS and DFS, respectively, and further analysis demonstrated that ethnicity, sample size, and histopathological origin were considered to be the main factors affecting their heterogeneity. In addition, high Pim-1 was associated with lymph node metastasis (OR 1.40 [95% CI 1.02-1.92], P = .04), distant metastasis (OR 2.69 [95%CI 1.67-4.35], P < .0001), and clinical stage III-IV (OR .7 [95% CI .50-.96, P = .03). Sensitivity analysis suggested that the pooled results of each effect-size were stable and reliable, and there was no significant publication bias (P = .138) in all included articles. CONCLUSION: High Pim-1 can not only predict poor OS and DFS of cancer, but also help to infer the malignant clinical characteristics of tumor metastasis. Pim-1 may be a potential and promising biomarker for early diagnosis, prognostic analysis and targeted therapy of tumors.
format Online
Article
Text
id pubmed-9290152
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-92901522022-07-19 Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics Lai, Lin Chen, Xinyu Tian, Ge Liang, Renba Chen, Xishan Qin, Yuelan Chen, Kaihua Zhu, Xiaodong Cancer Control Original Research Article BACKGROUND: Pim-1 is overexpressed in cancer tissues and plays a vital role in carcinogenesis. However, its clinical significance in cancers is not fully verified by meta-analysis, especially in relation to prognosis and clinicopathological features. METHODS: Four databases, PubMed, Embase, Cochrane Library, and Web of Science, were searched. Literature screening and data extraction according to the inclusion and exclusion criteria. The quality of the included literatures was evaluated using the Newcastle-Ottawa scale and the data analysis was performed using STATA and Review Manager software. RESULTS: 15 articles were finally included for meta-analysis, involving 1651 patients. Effect-size pooling analysis showed that high Pim-1 was related to poor overall survival (OS) (HR 1.68 [95% CI 1.17-2.40], P = .004) and disease-free survival (DFS) (HR 2.15 [95 %CI 1.15-4.01], P = .000). Subgroup analysis indicated that the detection techniques of Pim-1 were the main sources of heterogeneity, and 2 literatures using quantitative polymerase chain reaction (qPCR) for Pim-1mRNA had high homogeneity (I(2) = .0%, P = .321) in OS. Another 13 studies that applied immunohistochemistry (IHC) for Pim-1 protein had significant heterogeneity (I(2)=82.2%, P = .000; I(2)=92%, P = .000) in OS and DFS, respectively, and further analysis demonstrated that ethnicity, sample size, and histopathological origin were considered to be the main factors affecting their heterogeneity. In addition, high Pim-1 was associated with lymph node metastasis (OR 1.40 [95% CI 1.02-1.92], P = .04), distant metastasis (OR 2.69 [95%CI 1.67-4.35], P < .0001), and clinical stage III-IV (OR .7 [95% CI .50-.96, P = .03). Sensitivity analysis suggested that the pooled results of each effect-size were stable and reliable, and there was no significant publication bias (P = .138) in all included articles. CONCLUSION: High Pim-1 can not only predict poor OS and DFS of cancer, but also help to infer the malignant clinical characteristics of tumor metastasis. Pim-1 may be a potential and promising biomarker for early diagnosis, prognostic analysis and targeted therapy of tumors. SAGE Publications 2022-07-16 /pmc/articles/PMC9290152/ /pubmed/35844176 http://dx.doi.org/10.1177/10732748221106268 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Lai, Lin
Chen, Xinyu
Tian, Ge
Liang, Renba
Chen, Xishan
Qin, Yuelan
Chen, Kaihua
Zhu, Xiaodong
Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics
title Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics
title_full Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics
title_fullStr Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics
title_full_unstemmed Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics
title_short Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics
title_sort clinical significance of pim-1 in human cancers: a meta-analysis of association with prognosis and clinicopathological characteristics
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290152/
https://www.ncbi.nlm.nih.gov/pubmed/35844176
http://dx.doi.org/10.1177/10732748221106268
work_keys_str_mv AT lailin clinicalsignificanceofpim1inhumancancersametaanalysisofassociationwithprognosisandclinicopathologicalcharacteristics
AT chenxinyu clinicalsignificanceofpim1inhumancancersametaanalysisofassociationwithprognosisandclinicopathologicalcharacteristics
AT tiange clinicalsignificanceofpim1inhumancancersametaanalysisofassociationwithprognosisandclinicopathologicalcharacteristics
AT liangrenba clinicalsignificanceofpim1inhumancancersametaanalysisofassociationwithprognosisandclinicopathologicalcharacteristics
AT chenxishan clinicalsignificanceofpim1inhumancancersametaanalysisofassociationwithprognosisandclinicopathologicalcharacteristics
AT qinyuelan clinicalsignificanceofpim1inhumancancersametaanalysisofassociationwithprognosisandclinicopathologicalcharacteristics
AT chenkaihua clinicalsignificanceofpim1inhumancancersametaanalysisofassociationwithprognosisandclinicopathologicalcharacteristics
AT zhuxiaodong clinicalsignificanceofpim1inhumancancersametaanalysisofassociationwithprognosisandclinicopathologicalcharacteristics